Phase 2: Engineering antigen-specific regulatory T cells for use in type 1 diabetes
|Effective start/end date||9/1/20 → 8/31/23|
- LEONA M & HARRY B HELMSLEY CHAR. TRUST
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.